$1.43+0.05 (+3.62%)
Nano Dimension Ltd., together with its subsidiaries, provides industrial manufacturing solutions for design-to-manufacturing of electronics and mechanical parts in the Americas, the Asia Pacific, Europe, the Middle East, and Africa.
Nano Dimension Ltd. in the Technology sector is trading at $1.43 with a market capitalization of $273M. The stock is currently 38% below its 52-week high of $2.32, remaining 15.9% below its 200-day moving average. On fundamentals, Piotroski 3/9 flags weak fundamentals, Altman Z in the distress zone. The Whystock Score of 15/100 signals elevated caution as multiple indicators diverge.
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $29.73M↓ | $35.31M↑ | $26.88M↑ | $25.84M↑ | $14.40M |
| Gross Profit | $12.13M↓ | $13.32M↑ | $8.14M↑ | $7.04M↑ | $5.84M |
| Operating Income | -$20.98M↑ | -$22.00M↑ | -$24.69M↑ | -$33.17M↓ | -$11.41M |
| Net Income | -$69.66M↓ | -$33.94M↑ | -$53.01M↑ | -$181.04M↓ | -$25.31M |
Nano Dimension Ltd., together with its subsidiaries, provides industrial manufacturing solutions for design-to-manufacturing of electronics and mechanical parts in the Americas, the Asia Pacific, Europe, the Middle East, and Africa. Its product group...
Nano Dimension Ltd. (NASDAQ:NNDM) is one of the 8 High Growth Penny Stocks to Buy. On June 15, 2026, Nano Dimension Ltd. (NASDAQ:NNDM) entered into a non-binding term sheet for a proposed business combination with Infinite Epigenetics. The proposed transaction contemplates Nano Dimension, or a successor publicly traded company, acquiring 100% of Infinite Epigenetics through […]
13D FILINGS These disclosures are from 13Ds filed with the Securities and Exchange Commission. 13Ds are filed within 10 days of an entity’s attaining more than 5% in any class of a company’s securities.
Nano Dimension Ltd. (Nasdaq: NNDM) (“Nano Dimension,” “Nano”, or the “Company”) and Infinite Epigenetics™ (“Infinite Epigenetics,” “Infinite”) today issued the following shareholder update to provide additional detail on the proposed business combination announced on June 15, 2026. The Company has carefully reviewed Murchinson’s recent letter regarding the proposed transaction with Infinite.
Nano Dimension Ltd. (Nasdaq: NNDM) (“Nano Dimension,” “Nano”) today announced it has entered into a non-binding term sheet for a proposed business combination (“combination”) with Infinite Epigenetics™ (“Infinite Epigenetics,” “Infinite”), an artificial intelligence (“AI”)-powered preventive health and diagnostics company building a proprietary biological AI platform to read, interpret, and apply epigenetic signals at scale. Epigenetics is the science of gene expression, shaped by lifestyle, aging, stress, and environmental factors. While traditional genetics dictates the exact sequence of one's DNA, epigenetics serves as a set of switches that can turn genes "on" or "off" without altering the underlying code.
With a short percentage of shares outstanding of 3.15%, Stratasys Ltd. (NASDAQ:SSYS) is among the 7 Best 3D Printing Stocks to Buy for Aerospace Components. Stratasys Ltd. (NASDAQ:SSYS) strengthened its strategic positioning on June 2 with the opening of its new Americas Regional Corporate Headquarters, a 200,000-square-foot facility in Minnetonka, Minnesota. Management emphasized that the new center […]